Concentration, Separation, Or Purification Of Micro-organisms Patents (Class 435/173.9)
-
Publication number: 20130224822Abstract: Genetically engineered algae strains for biofuels and bioproduct production have improved iron utilization including iron uptake and storage, and exhibit improved growth characteristics, magnetic separation, and magnetic hysteresis induced cell lysis. Pond production algal strain embodiments with high iron scavenging capabilities limit iron availability to contaminating microorganisms and invading species. Accumulation of high iron and other paramagnetic elements content in the form of ferritin enhances the cells magnetic susceptibility improving efficiency of magnetic separation and magnetic hysteresis induced cell lysis. Several genes of the embodiments are capable of improving iron acquisition including the ferritin gene fer1, iron transport gene fea1, and iron reductase gene fre1.Type: ApplicationFiled: July 7, 2011Publication date: August 29, 2013Inventors: Richard Sayre, Brad Postier
-
Publication number: 20130210109Abstract: The invention provides methods for depleting extraneous phenotypes from a mixed population of cells comprising the in vitro differentiated progeny of primate pluripotent stem cells. The invention also provides mixed cell populations enriched for a target cell phenotype where the mixed cell population comprises the differentiated in vitro progeny of primate embryonic stem cells.Type: ApplicationFiled: November 16, 2012Publication date: August 15, 2013Inventor: Geron Corporation
-
Patent number: 8507237Abstract: The invention concerns a device and a method for concentrating pathogenic germs potentiaily present in blood products or derivatives and for detecting said germs comprising the following steps: (a) subjecting a sample of said blood product to a blood cell aggregating treatment, (b) eliminating the aggregates formed at step (a) by passing the treated sample over a first filter allowing through the contaminating germs but not the cell aggregates, (c) selectively lyzing the residual cells of the filtrate obtained at step (b), (d) recuperating the contaminating germs by passing the lysate of step (c) over a second filter to detect the contaminating germs possibly trapped.Type: GrantFiled: March 8, 2004Date of Patent: August 13, 2013Assignee: GeneOhm Sciences, Inc.Inventors: Jean-Pierre Hermet, Isabelle Besson-Faure, Sébastien Ribault, Yann Godfrin, Anne Monnot des Angles
-
Patent number: 8507236Abstract: Systems and methods for controlling an object are disclosed. In one embodiment, a system and method pertain to irradiating the object with polarized electromagnetic radiation for a duration of time sufficient to effect a physical change with the object.Type: GrantFiled: June 1, 2010Date of Patent: August 13, 2013Assignee: University of Central Florida Research Foundation, Inc.Inventors: Aristide Dogariu, Kiminobu Sugaya, Gabriel Biener
-
Publication number: 20130189754Abstract: The present relation relates to recombinant vesicular stomatitis virus for use as prophylactic and therapeutic vaccines for infectious diseases of AIDS. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.Type: ApplicationFiled: September 12, 2012Publication date: July 25, 2013Applicant: INTERNATIONAL AIDS VACCINE INITIATIVEInventors: Christopher L. Parks, Christy Jurgens, Perry J. Tiberio, Simon Hoffenberg
-
Publication number: 20130189755Abstract: The present invention relates to an apparatus for separating fine particles using magnetophoresis, and to a method for separating fine particles using same, and particularly, to an apparatus for separating fine particles using magnetophoresis, which includes a fine, patterned magnetic structure capable of quickly and efficiently separating even particles that are weakly magnetized and coupled to fine particles, and to a method for separating fine particles using same.Type: ApplicationFiled: August 19, 2011Publication date: July 25, 2013Applicant: INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Ki Ho Han, Hwan Yong Lee, Song l Han, Seon Young Kim, In Hak Choi
-
Patent number: 8476063Abstract: Methods and devices for the interfacing of microchips to various types of modules are disclosed. The technology disclosed can be used as sample preparation and analysis systems for various applications, such as DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense.Type: GrantFiled: June 15, 2010Date of Patent: July 2, 2013Assignee: IntegenX Inc.Inventors: Stevan Bogdan Jovanovich, Iuliu Ioan Blaga
-
Publication number: 20130130236Abstract: A method for separating labeled cells and a use (of the labeled cells) thereof are provided. More specifically, a method for labeling cells using fluorescent magnetic nanodiamonds, and a method for separating the labeled cells using the labeling method by the fluorescent or magnetic properties of the nanodiamonds are provided.Type: ApplicationFiled: May 15, 2012Publication date: May 23, 2013Applicant: NATIONAL CHIAO TUNG UNIVERSITYInventors: Jui-I Chao, Zhi-Yi Lien, Kuo-Chu Hwang
-
Patent number: 8440440Abstract: Methods of treating using adipose tissue using ultrasonic cavitation to dissociate the fat cells and blood vessels contained within adipose tissue and thereby obtain mesenchymal or stromal vascular fractions for use in human subjects are provided. These methods preferably do not include the use of any exogenous dissociating enzymes such as collagenase and result in increased numbers of the cells which constitute the mesenchymal or stromal vascular fractions (about 10-fold greater) than methods which use collagenase to isolate these cells.Type: GrantFiled: December 12, 2011Date of Patent: May 14, 2013Assignee: Intellicell Biosciences Inc.Inventor: Steven Victor
-
Patent number: 8431390Abstract: Methods and devices for the interfacing of microchips to various types of modules are disclosed. The technology disclosed can be used as sample preparation and analysis systems for various applications, such as DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense.Type: GrantFiled: November 2, 2011Date of Patent: April 30, 2013Assignee: IntegenX Inc.Inventors: Stevan Bogdan Jovanovich, Iuliu Ioan Blaga
-
Patent number: 8431026Abstract: A system for concentrating magnetic particles suspended in a fluid comprising a vessel for containing said fluid having an inner base surface that slopes downwards towards a collection region, the collection region including a retrieval well for collecting magnetic particles; a magnet assembly for positioning under and in proximity with the vessel for attracting magnetic particles to the bottom surface of the vessel, said magnet assembly providing a relatively larger magnetic flux density at a peripheral region thereof; means for laterally traversing the magnet assembly relative to the vessel between a first position whereby the magnet is generally centered under the vessel and a second position whereby the peripheral portion of the magnet is positioned under the well of the vessel; and agitation means for agitating said vessel to facilitate movement of the magnetic particles to the well, where the concentrated particles can be easily removed.Type: GrantFiled: December 15, 2010Date of Patent: April 30, 2013Inventor: Anthony N. Sharpe
-
Patent number: 8431340Abstract: Methods and devices for the interfacing of microchips to various types of modules are disclosed. The technology disclosed can be used as sample preparation and analysis systems for various applications, such as DNA sequencing and genotyping, proteomics, pathogen detection, diagnostics and biodefense.Type: GrantFiled: October 23, 2009Date of Patent: April 30, 2013Assignee: IntegenX Inc.Inventors: Stevan Bogdan Jovanovich, Iuliu Ioan Blaga
-
Patent number: 8426205Abstract: Disclosed is a method for selective electrofusion of at least two fusion partners having cell-like membranes and cellular or subcellular dimensions, comprising the following steps: A) the fusion partners are brought into contact with each other and B) an electrical field of a strength sufficient to obtain fusion and highly focused on the fusion partners is applied. The fusion partners are independently selected from the group consisting of a single cell, a liposome, a proteoliposome, a synthetic vesicle, an egg cell, an enucleated egg cell, a sperm cell at any development stage and a plant protoplast.Type: GrantFiled: July 23, 2012Date of Patent: April 23, 2013Assignee: Collectricon ABInventors: Peter Eriksson, Daniel T. Chiu, Alexander Moscho, Owe Orwar, Richard N. Zare
-
Patent number: 8426214Abstract: System and method for capturing, concentrating, and detecting a diagnostic target in a liquid, comprising applying a magnetic field to a mixture comprising a co-aggregate in the liquid to provide a collected co-aggregate in the liquid, wherein the co-aggregate comprises a magnetic particle having a stimuli-responsive polymer attached thereto and a non-magnetic particle having a stimuli-responsive polymer and a diagnostic target attached thereto.Type: GrantFiled: June 14, 2010Date of Patent: April 23, 2013Assignee: University of WashingtonInventors: Patrick S. Stayton, Michael Nash, Jriuan Lai
-
Publication number: 20130089909Abstract: Magnetic particles capable of binding a target substance, which comprise a magnetic material and a matrix material, wherein the magnetic material is remanent upon exposure to a magnetic field and the matrix material has a surface comprising functional groups which promote disaggregation of the particles in the presence of a liquid phase.Type: ApplicationFiled: October 2, 2012Publication date: April 11, 2013Applicant: SINVENT ASInventor: SINVENT AS
-
Patent number: 8399229Abstract: Magnetic array platforms such as nano or micro-wire networks that produce trapping, manipulation, and transport of micro- or nano-scale particles such as non-biological entities such as magnetic particles and cells, viruses, DNA, proteins, and other biological entities having magnetic particles labeled or tethered thereto are provided. Methods of manipulating, transporting, and sorting micro- or nano-scale particles are described.Type: GrantFiled: November 19, 2010Date of Patent: March 19, 2013Assignee: The Ohio State UniversityInventors: Ratnasingham Sooryakumar, Dhriti Sooryakumar, Gregory Vieira, Jeffrey J. Chalmers
-
Publication number: 20130034560Abstract: The present invention relates to proteins and/or fragments and derivatives thereof and their use as vaccines and in biotechnological methods. The vaccines particularly include immunogenic proteins in Treponema spp. isolated from digital dermatitis in cattle. The present invention further relates to antibodies raised against said proteins or fragments thereof, and the use of said proteins in diagnostic methods in which antibodies are detected as a sign of digital dermatitis in cattle.Type: ApplicationFiled: January 28, 2011Publication date: February 7, 2013Inventors: Anna Rosander, Märit Pringle
-
Publication number: 20130023025Abstract: A method for separating cells which includes: adhering cells to the surface of a cell culture substrate containing a photo-acid generator that generates an acidic substance upon irradiation with active energy rays, and irradiating only a partial region of the cell culture substrate with the active energy rays to selectively remove the cells within the partial region, thereby separating the cells within the partial region and cells in other regions.Type: ApplicationFiled: March 28, 2011Publication date: January 24, 2013Inventors: Kimio Sumaru, Toshiyuki Takagi, Kyoko Kikuchi, Taku Sato, Manae Yamaguchi, Toshiyuki Kanamori
-
Publication number: 20130023024Abstract: A conjugate is provided for cell processing, which comprises a magnetic particle and a surface modifier having specific affinity to a target cell. The particle and modifier are linked through a cleavable peptide bond. In a method of cell processing, the conjugate is attached to a target cell; the target cell attached to the conjugate is subject to magnetic processing; the peptide bond is cleaved to separate the processed target cell from the magnetic particle; the target cell separated from the magnetic particle is attached to a substrate. The magnetic particle may include an iron oxide, and the surface modifier may include a glucosamine. The particle and modifier may be linked by a linker comprising a protease recognition site and a peptide bond. The linker links the surface modifier to the particle, and cleavage of the peptide bond is catalyzed by a specific protease that recognizes the protease recognition site.Type: ApplicationFiled: March 31, 2011Publication date: January 24, 2013Inventors: Jackie Y. Ying, Karthikeyan Narayanan, Alex Wei Haw Lin, Andrew Chwee Aun Wan, Yuangang Zheng, Nandanan Erathodiyil
-
Publication number: 20130017538Abstract: Methods, microfluidic devices, and instruments for magnetic separation of particles from a fluid are described. Examples include microfluidic devices having a removable portion. Examples include microfluidic devices having one or more regions of reduced fluid velocity. Examples further including instruments having pneumatic interfaces. Examples further includes instruments having controllable magnets, imaging components, or combinations thereof.Type: ApplicationFiled: July 14, 2011Publication date: January 17, 2013Applicant: Fluxion Biosciences Inc.Inventors: Cristian Ionescu-Zanetti, Joshua Tanner Nevill, Michael Schwartz, Carolyn G. Conant, Roger Rudoff
-
Publication number: 20130011899Abstract: The present invention relates to a cell fusion chamber in which two types of cells having different diameters are fused, the cell fusion chamber including: a cell fusion region in which cell fusion is carried out; a pair of electrodes formed by a conductor and disposed opposite to each other in the cell fusion region; and a partition wall having at least one fine pore; near the fine pore, a cell fusion device including a cell fusion container containing a cell fusion region; a pair of electrodes; a spacer; and an insulator disposed between the spacer and one of the electrodes and having at least one fine pore; and an electronic power supply which applies an alternating voltage and a voltage pulsed direct current to the electrodes, and a cell fusion method using the same.Type: ApplicationFiled: September 14, 2012Publication date: January 10, 2013Applicant: TOSOH CORPORATIONInventors: Toru FUTAMI, Takahiro Maruyama, Atsushi Morimoto
-
Patent number: 8343440Abstract: A cancer cell separating apparatus includes: a flow channel including an antibody fixation area having antibodies which bind specifically to cancer cells fixed thereon, wherein the cancer cells and non-cancer cells are separated using a difference in velocity of movement between the cancer cells and the non-cancer cells in cell slurry introduced into the flow channel.Type: GrantFiled: March 23, 2010Date of Patent: January 1, 2013Assignee: Seiko Epson CorporationInventor: Satomi Yoshioka
-
Publication number: 20120329123Abstract: Disclosed is a method for detaching cultured cells that can selectively detach cultured adhered cells. The scaffold to which the cells adhere is configured from at least a cell adhesion factor containing carbon nanotubes, and by means of radiating laser light in a spot shape on the scaffold in a region where cells are adhered, a shock wave is generated by the heat arising by means of the photothermal conversion of the carbon nanotubes, and by means of this shock wave, the cells are caused to be in a non-adhered state.Type: ApplicationFiled: February 28, 2011Publication date: December 27, 2012Inventors: Naotoshi Nakashima, Tsuyohiko Fujigaya, Kouji Nakazawa, Yasuro Niidome
-
Patent number: 8329437Abstract: A single-use disposable cartridge and reusable interrogation platform for interrogating particles in a fluid carrier medium. The cartridge includes a micro-electro-mechanical system (MEMS) embodied in a chip to perform electrical property interrogations of fluid flowing in a micro channel. Desirably, the microchannel is sized to cause single-file particle flow past a sensor portion of the MEMS chip.Type: GrantFiled: December 16, 2009Date of Patent: December 11, 2012Assignee: E.I. Spectra, LLCInventor: Harold E. Ayliffe
-
Publication number: 20120301883Abstract: The invention relates generally to fluid processing and, in particular aspects, processing fluids for detection, selection, trapping and/or sorting of particulate moieties. Sheath flow devices described allow isolation of target species from fluid samples while avoiding non-specific binding of unwanted species to the surfaces of the separation device. Biological fluid processing, detection, sorting or selection of cells, proteins, and nucleic acids is described. The invention finds particular use in diagnostic settings, analyzing a patient's medical condition, monitoring and/or adjusting a therapeutic regimen and producing cell based products.Type: ApplicationFiled: August 3, 2012Publication date: November 29, 2012Applicant: CYNVENIO BIOSYSTEMS, INC.Inventors: Paul Pagano, Yanting Zhang, Jiangrong Karen Qian, Hyongsok Tom Soh, Paul W. Dempsey, Andre' De Fusco
-
Publication number: 20120258451Abstract: Methods for laser microdissection isolation of viable cells are provided. Cells of a desired type may be isolated from a diverse population, optionally with detection and exclusion of undesired cells. Desired cells may be isolated from a population that arose from differentiation of pluripotent cells, preferably embryonic stem cells or induced pluripotent stem cells, and undifferentiated stem cells may be detected and excluded from selection including the isolation of RPE cells sleeted based on morphology (e.g., characteristic mottled appearance) from a population of ES cells. The cells isolated by these methods, including RPE cells, may be essentially free of undifferentiated cells and thus suitable for use in cell-based therapies.Type: ApplicationFiled: April 6, 2012Publication date: October 11, 2012Applicant: Advanced Cell Technology, Inc.Inventor: Irina Vitaly KLIMANSKAYA
-
Patent number: 8283167Abstract: Labeled annexin is formed by reacting annexin or a modified annexin with a phosphatidylserine group or an analogue of phosphatidylserine. This phosphatidylserine annexin conjugate is then reacted with an appropriate label to form a labeled annexin and the annexin is separated from the phosphatidylserine group. The reaction between the phosphatidylserine group and the annexin is calcium ion concentration dependent. Therefore, the reaction can be promoted by having a high calcium ion concentration and the separation of the phosphatidyl group from the annexin group is facilitated by reducing the calcium ion concentration preferably by addition of an appropriate calcium chelating agent.Type: GrantFiled: February 4, 2010Date of Patent: October 9, 2012Assignee: Clear Vascular Inc.Inventor: Jaime Simon
-
Publication number: 20120253238Abstract: Solubilizing compositions are provided. The compositions comprise at least one zwitterionic surfactant and at least one nonionic surfactant. In one embodiment, the compositions may be useful for solubilizing and remodeling and/or removing tissue on or beneath a patient's skin, optionally in conjunction with the application of energy to a region of interest on the skin. In one embodiment, at least one analyte may be collected and analyzed from the solubilized tissue.Type: ApplicationFiled: May 16, 2012Publication date: October 4, 2012Inventors: Samir Mitragotri, Russell M. Lebovitz, Beyeong Hee Hwang
-
Publication number: 20120252088Abstract: A cell isolation device with an inner freely floating magnetic probe to capture and collect biological cells, such as circulating tumor cells (CTCs), during immunomagnetic incubation provides a highly efficient, low cost method to collect target cells at a single cell level. A special membrane filter may be placed above a wash well to enable separation of collected cells from free magnetic beads to yield high purity cells enabling accurate cell count. The novel approach provides a faster turn-around to separate target cells from blood, marrow or other samples with efficient removal of free magnetic beads. Cancel cell spiking experiments show a recovery rate of greater than 85%.Type: ApplicationFiled: November 15, 2011Publication date: October 4, 2012Inventors: Jie Zhang, Glenn Y. Deng, Fang Tien
-
Publication number: 20120244129Abstract: Objects of the present invention are to provide a method for directly obtaining pluripotent stem cells which do not have tumorigenic property from body tissue and the thus obtained pluripotent stem cells. The present invention relates to SSEA-3 (+) pluripotent stem cells that can be isolated from body tissue.Type: ApplicationFiled: March 30, 2012Publication date: September 27, 2012Inventors: Mari Dezawa, Yoshinori Fujiyoshi, Youichi Nabeshima, Shohei Wakao, Masanori Yoshida, Yasumasa Kuroda
-
Publication number: 20120237997Abstract: A device for separating a sample of cells suspended in a bio-compatible ferrofluid is described. The device includes a microfluidic channel having a sample inlet, at least one outlet and a length between the same inlet and the at least one outlet, wherein a sample can be added to the sample inlet and flow along the microfluidic channel length to the at least one outlet. The device includes a plurality of electrodes and a power source for applying a current to the plurality of electrodes to create a magnetic field pattern along the microfluidic Channel length. The present invention also includes a method of using said device for separating at least one cell type.Type: ApplicationFiled: December 7, 2010Publication date: September 20, 2012Applicant: Yale UniveristyInventor: Hur Koser
-
Patent number: 8268603Abstract: An apparatus for disrupting cells or viruses comprises a container having a chamber for holding the cells or viruses. The container includes at least one flexible wall defining the chamber. The apparatus also includes a transducer for impacting an external surface of the flexible wall to generate pressure waves in the chamber. The apparatus also includes a pressure source for increasing the pressure in the chamber. The pressurization of the chamber ensures effective coupling between the transducer and the flexible wall. The apparatus may also include beads in the chamber for rupturing the cells or viruses.Type: GrantFiled: September 22, 2005Date of Patent: September 18, 2012Assignee: CepheidInventors: Michael T. Taylor, Phillip Belgrader, Farzad Pourahmadi, William A. McMillan, Ronald Chang, Jesus Ching
-
Publication number: 20120230963Abstract: Methods for producing a population of human-derived glial restricted progenitor cells (GRPs) with decreased potentially unintended or undesired cellular phenotypes and/or decreased standard deviation in the cells of the population are provided. Also provided are antibody panels and gene expression profiles to characterize GRPs and a method for its use in characterizing GRP cells. In addition methods for use of these GRP cells to generate astrocytes and/or oligodendrocytes, to re-myelinate neurons and to treat glial cell related and other neurodegenerative diseases or disorders or injuries or damage to the nervous system are provided. A method to manufacture neural cells depleted of A2B5 positive cells is also provided.Type: ApplicationFiled: November 9, 2010Publication date: September 13, 2012Applicant: Q Therapeutics, Inc.Inventors: Robert Sandrock, James T. Campanelli, Deborah A. Eppstein
-
Patent number: 8252161Abstract: Method for improving selectivity and productivity during purification of charged macromolecules and particles by electrofiltration by means of membranes in the electric filed. The ratio between the electric field and the permeate flow through the membrane is kept constant.Type: GrantFiled: March 6, 2006Date of Patent: August 28, 2012Assignee: Bayer Technology Services GmbHInventors: Gregor Dudziak, Michael Traving, Martina Mutter
-
Patent number: 8247204Abstract: Magnetic enrichment method, wherein the desired biological component is collected from a solution, which component is thereafter enriched in a liquid in such a manner that by means of the micro particles attached to the magnet or attached by means of at least one magnet at least one biological component is collected in a closed reactor vessel. Thereafter at least one biological component is enriched in such a manner that the desired component is released to the solution. The reactor unit is a closed vessel, wherein the prevailing conditions are controllable. The shape and the location of the magnet unit in the reactor unit are adjusted in a preferable manner to collect the desired biological component.Type: GrantFiled: October 20, 2004Date of Patent: August 21, 2012Assignee: BioControl Systems, Inc.Inventors: Matti Korpela, Kenneth Rundt
-
Publication number: 20120190040Abstract: The present invention provides a microfluidic devices and methods of use thereof for the concentration and capture of cells. A pulsed non-Faradic electric field is applied relative to a sample under laminar flow, which results to the concentration and capture of charged analyte. Advantageously, pulse timing is selected to avoid problems associated with ionic screening within the channel. At least one of the electrodes within the channel is coated with an insulating layer to prevent a Faradic current from flowing in the channel. Under pulsed application of a unipolar voltage to the electrodes, charged analyte within the sample is moved towards one of the electrodes via a transient electrophoretic force.Type: ApplicationFiled: July 30, 2010Publication date: July 26, 2012Applicant: QVELLA CORPORATIONInventors: Samad Talebpour, Aye Aye Khine, Stephen W. Leonard, Robert Maaskant, Tino Alavie
-
Compact disk based system for separating immunomagnetic bead labeled particulates and method thereof
Patent number: 8226826Abstract: Disclosed is a disk based system for separating at least two types of particulates contained in a sample fluid. The system includes a disk-like carrier board and a magnetic attraction unit. The disk-like carrier board forms at least one flow channel structure, which includes an inner reservoir, at least one separation chamber, and at least one outer reservoir arranged in sequence from a geometric center of the disk-like carrier board to an outer circumferential rim of the disk-like carrier board. A method of separation carried out with the system includes introducing the sample fluid into the inner reservoir and then rotating the disk-like carrier board to induce a centrifugal force. The sample fluid contains particulates that are labeled with immunomagnetic beads and the labeled particulates are attracted by the magnetic force generated by the magnetic attraction unit to retain in the inner reservoir or the separation chamber.Type: GrantFiled: June 25, 2009Date of Patent: July 24, 2012Assignee: National Taiwan UniversityInventors: Andrew M. Wo, Chen-Lin Chen, Ken-Chao Chen, Yu-Cheng Pan -
Publication number: 20120184010Abstract: A microfluidic system (1) for the isolation of cells (C1) of at least one given type from a sample; the system (1) comprises a separation unit (3), for transferring at least part of the cells (C1) of the given type from a main chamber (4) to a recovery chamber (5) in a substantially selective way with respect to further cells (C2) of the sample; two valves (9, 10) are set upstream and downstream of the main chamber (4); two valves (11, 12) are set upstream and downstream of the recovery chamber (5); a control assembly (23) is designed to govern the aforementioned valves (9, 10, 11, 12); the system (1) proposed enables isolation of the cells with a high degree of reproducibility and precision.Type: ApplicationFiled: March 17, 2010Publication date: July 19, 2012Applicant: SILICON BIOSYSTEMS S.P.A.Inventors: Gianni Medoro, Gerardo Perozziello, Alex Calanca, Giuseppina Simone, Nicolò Manaresi
-
Publication number: 20120177616Abstract: The subject matter of this invention is a novel method to augment the process of obtaining populations of placental hematopoietic stem and progenitor cells for use in medical practices. A method of augmentation of stem cells collection from placenta is claimed comprising the steps of (a) infusing placental vessels cell preservation compound and a with a composition containing blockers of cell adhesion receptors, (b) incubating said placenta for a sufficient period of time, (c) placing placenta in a containment with sufficient intensity of electromagnetic or ultrasound field for a sufficient period of time; (d) eluting cell suspension from placental vessels, (e) collecting cell suspension and harvesting cells. Invention further claims a method of treatment a disease by means of administering therapeutic composition containing said placental-derived hematopoietic stem cells.Type: ApplicationFiled: December 12, 2011Publication date: July 12, 2012Applicant: Plasalus LLCInventors: Vladimir B. Serikov, Frans A. Kuypers
-
Publication number: 20120164113Abstract: Methods of treating using adipose tissue using ultrasonic cavitation to dissociate the fat cells and blood vessels contained within adipose tissue and thereby obtain mesenchymal or stromal vascular fractions for use in human subjects are provided. These methods preferably do not include the use of any exogenous dissociating enzymes such as collagenase and result in increased numbers of the cells which constitute the mesenchymal or stromal vascular fractions (about 10-fold greater) than methods which use collagenase to isolate these cells.Type: ApplicationFiled: December 12, 2011Publication date: June 28, 2012Inventor: Steven Victor
-
Publication number: 20120135494Abstract: A magnetic separator comprising a separation chamber is provided. The magnetic separator comprises an inlet and at least one outlet, and a magnetic source operatively coupled to the separation chamber and comprising a plurality of magnets that can be selectively turned off and on to create a dynamic magnetic field in the separation chamber.Type: ApplicationFiled: November 30, 2010Publication date: May 31, 2012Applicant: GENERAL ELECTRIC COMPANYInventors: Sunil Srinivasa Murthy, James William Bray, Shankar Chandrasekaran, Arvind Kumar Tiwari, Aaron Joseph Dulgar-Tulloch, Munish Vishwas Inamdar
-
Patent number: 8187886Abstract: The invention relates to methods of isolating white blood cells (WBCs) from a sample, e.g., whole blood, using magnetic particles that specifically bind to WBCs and a series of specific steps and conditions. The methods can include one or more of decreasing the viscosity of the sample prior to WBC isolation, agitating the sample at specified frequencies, and/or using a sample container arranged such that all of the sample is placed in close proximity (e.g., within 5, 2, 1, or 0.5 mm) to the source of the magnetic field. The new methods provide for isolation of WBC preparations with high yield, purity, and viability. The methods are designed for compatibility with automation protocols for rapid processing of multiple samples.Type: GrantFiled: January 10, 2011Date of Patent: May 29, 2012Assignee: The General Hospital CorporationInventors: Denise L. Faustman, Douglas E. Burger
-
Publication number: 20120122124Abstract: The present invention relates to bacteriophage adhesion proteins binding to the O-antigen of gram negative bacteria, lacking the ability of binding to a bacteriophage and of hydrolysing lipopolysaccharides. The invention further relates to nucleic acid molecules comprising a sequence encoding the proteins according to the present invention. In addition, the present invention relates to a method for generating bacteriophage adhesion proteins according to the present invention. The invention further relates to the use of said proteins and methods of detection, purification and enrichment of bacteria.Type: ApplicationFiled: July 3, 2009Publication date: May 17, 2012Inventors: Manfred Biebl, Renate Grassl, Monika Walter, Stefan Miller
-
Patent number: 8178341Abstract: A system for exposing a target material to small particles. The system includes an exposure chamber that receives the target material. A stream of charged particles is directed via an inlet into the exposure chamber toward the target material. One or more electrodes are located relative to the target material and the inlet, and are electrically charged, so as to cause at least some of the charged particles to impact upon the target material. The system can be used to expose the target material to small, for example, nanoscale, particles in a gas environment.Type: GrantFiled: August 23, 2007Date of Patent: May 15, 2012Assignee: The University of Vermont and State Agricultural CollegeInventor: Giuseppe A. Petrucci
-
Publication number: 20120115167Abstract: A method for isolating a target bioentity from a biological sample, comprises contacting the biological sample with a magnetically-labelled ligand having selective binding affinity for the target bioentity, or for a determinant on the target bioentity, to form a target bioentity/labelled ligand complex, locating a separation module having a defined fluid flow path in the magnetic field of a magnetic module, the magnetic module comprising an array of at least two magnets in which adjacent magnets in the array are aligned with opposing polarity; passing the biological sample through the separation module to subject the biological sample to the magnetic field while the sample is passing through the defined fluid flow path to magnetically capture the target bioentity/labelled ligand complex by arresting or hindering movement of the complex within the defined fluid flow path; removing the separation module from the magnetic field; and recovering the target bioentity/labelled ligand complex from the fluid flow pathType: ApplicationFiled: April 22, 2010Publication date: May 10, 2012Applicant: CLINICAL GENOMICS PTY. LTD.Inventors: Howard Milne Chandler, Michael Bruce Chandler
-
Publication number: 20120107898Abstract: A method for obtaining human microglial precursor cells, comprising: (a) providing a cell population comprising neural precursor cells, wherein the cell population is obtainable from embryoid bodies differentiated from human pluripotent stem cells; (b) differentiating the cell population comprising neural precursor cells into microglial precursor cells by culturing in medium comprising a growth factor selected from the group consisting of insulin and insulin-like growth factors; (c) expanding and enriching microglial precursor cells in medium comprising a growth factor selected from the group consisting of insulin and insulin-like growth factors and 10 to 150 ng/ml GM-CSF; and (d) isolating microglial precursor cells comprising CD45-positive cells.Type: ApplicationFiled: April 28, 2010Publication date: May 3, 2012Inventors: Harald Neumann, Kristin Roy, Oliver Brüstle, Michael Peitz
-
Publication number: 20120064595Abstract: The present invention has as an object to simplify the implant work in a series of the process from the separation of target cells by dielectrophresis to the cell cultivation and to realize a cell accumulation method that prevents bacteria contamination by bacteria. Method to achieve the objects The cell accumulation device includes the accumulation and cultivation vessel having a first electrode unit 16, an aggregation of the plural number of individual electrodes, allocated on the first substrate and a second electrode unit 17 allocated on the second substrate.Type: ApplicationFiled: June 23, 2011Publication date: March 15, 2012Applicants: NISSHA PRINTING CO., LTD., KEIO UNIVERSITYInventors: Shogo Miyata, Shinya Takeuchi
-
Publication number: 20120045767Abstract: Magnetic beads that include polyvalent ligands comprising various carbohydrates are described. Methods for fabricating such magnetic beads are also provided as well as methods of their use to capture and enrich pathogen cell population for subsequent culture, lysis and identification.Type: ApplicationFiled: August 22, 2011Publication date: February 23, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Aldrich LAU, Robert Eason, Maxim Brevnov, Handong Li, Kevin Hacker
-
Publication number: 20120045763Abstract: This invention relates to antibodies that specific bind to fetal CD36+ cells in preference to binding to maternal CD36+ cells and methods for using these antibodies to detect and separate fetal cells from adult biological fluids including maternal peripheral blood.Type: ApplicationFiled: September 27, 2011Publication date: February 23, 2012Applicant: The Board of Trustees of the University of IllinoisInventors: Arun Sharma, Sherman Elias
-
Patent number: 8119976Abstract: A system, method, and device for re-orienting and/or deforming cells and other objects is provided. The system, method, and device may include a high-throughput setup that facilitates the ability to orient, deform, analyze, measure, and/or tag objects at a substantially higher rate than was previously possible. A relatively large number of cells and other objects can be deformed, by optical forces for example, as the cells and other objects a flowed through the system.Type: GrantFiled: July 2, 2008Date of Patent: February 21, 2012Assignee: Colorado School of MinesInventors: Jeff Squier, David W. M. Marr, Robert Applegate, Tor Vestad, Justin Chichester